Supreme Court Seeks Snapdeal's Reply on Prescription Drug Sale Liability
The apex court has sought responses from Snapdeal and its directors on Karnataka's plea challenging a High Court order that quashed criminal proceedings over a third-party seller's prescription drug sale. The case tests intermediary safe-harbour under Section 79 of the IT Act against sector-specific drug laws.
Supreme Court sought Snapdeal and its directors' reply on Karnataka's plea challenging a High Court order that quashed criminal proceedings over prescription drug sale by a third-party seller. Case tests ecommerce intermediary safe-harbour limits against sector-specific drug laws.
Why this matters
Follows the SC notice to Snapdeal over Karnataka's plea on ED drug sale without prescription. The liability question comes as Snapdeal expands seller programs like zero-commission Project Gati.
Retail-company signals are accelerating, up 881600% QoQ.
Also reported by
- Inc42 · Buzz — Same time